The Global Organization for EPA and DHA Omega-3s (GOED) has published the 2017-2018 edition of its annual Global EPA and DHA Omega-3 Ingredient Market Report.
Photo © iStockphoto.com/ evemilla
The Global Organization for EPA and DHA Omega-3s (GOED) has published the 2017-2018 edition of its annual Global EPA and DHA Omega-3 Ingredient Market Report. Top line data from the report shows that the total volume of omega-3 ingredients in 2018 increased 2.3% to 111,210 metric tons from 108,757 metric tons in 2017. Total market value of omega-3 ingredients also increased by 2.1% from $1,349,000 to $1,377,000.
The largest source of omega-3 ingredients, in terms of volume, was refined oils making up 36.6% of total volume, followed by concentrates (18.6%), miscellaneous pet food oils (16.1%), menhaden (8.5%), and cod liver oil (7.6%). In terms of value, concentrates commanded the largest proportion, used primarily for dietary supplements and pharmaceuticals (35.5%). This is followed by tuna and algae oil, important components of DHA-fortified infant formula (14.3% and 14.2%, respectively), then common refined and krill oils, used primarily in dietary supplements (13.7% and 7.4%, respectively).
The full report, with a full breakdown of the market and raw data, is available for purchase on the GOED website.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.